HOME >> BIOLOGY >> NEWS
Experimental Biology 2002, Translating the Genome

More than 14,000 biomedical researchers will gather in New Orleans April 20-24 for Experimental Biology 2002. Now in its eleventh year, the annual meeting brings together scientists from dozens of scientific disciplines and countries to present the newest scientific concepts and discoveries expected to shape future medical advances.

Whatever their fields of study, whether basic science or clinical research, scientists come to Experimental Biology meetings because of a shared interest in the processes underlying human development, function, aging, and the way diseases develop and can be treated or prevented. The size, scope and organization of the meeting give these scientists an unparalleled opportunity to step outside the boundaries of their own fields. They share information with scientists armed with the viewpoint and tools of entirely different disciplines.

The seven sponsoring societies for Experimental Biology 2002 are: The American Physiological Society, American Society for Biochemistry and Molecular Biology, American Society for Pharmacology and Experimental Therapeutics, American Society for Investigative Pathology, American Society for Nutritional Sciences, The American Association of Immunologists and American Association of Anatomists. Twenty-four guest societies from across the world, from the American Association of Veterinary Anatomists to the Spanish Physiological Society, represent an even broader range of interests and collaboration.

The theme for Experimental Biology 2002 is Translating the Genome. Recent advances in decoding the human genome, the complete set of genes in the human body, have given scientists in all fields a new tool in understanding how human beings function and develop or respond to disease. Experimental Biology 2002 gives them a chance to share their findings and perspectives.

For five days, scientists can choose among thousands of scientific presentations i
'"/>

Contact: Sarah Goodwin
eb2press@bellsouth.net
404-327-6437
Federation of American Societies for Experimental Biology
15-Mar-2002


Page: 1 2 3 4

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental Biology 2003 meets in San Diego April 11-15
10. Experimental gene switch increases lifespan with no ill effects
11. Experimental therapy stops allergic reactions in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... pleased to announce the next event in a series of TOPIQ webinars, which ... TOPIQ series of webinars was developed in response to social distancing measures that ...
(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to deliver ... analysis methods. The team has added experienced genealogists, each having over a decade ...
(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and gene ... Directors. , “Neil understands the need for a global perspective to make an impact ... Greffex. Mr. Bush will serve as an independent, director of the company. , “The ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced ... June 22-24 during the American Association for Cancer Research Virtual meeting. One poster ... potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a leading ... use of proprietary clean viral vectors, recently announced a key manufacturing agreement with ... platform is the world’s most successful gene therapy delivery vehicle (vector) with broad ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been ... the Paris Agreement to stock market dips, ways to reduce CO2 is something we ... their portfolio. Most of the biofuels being produced today are created from recycled cooking ...
(Date:5/30/2020)... ... May 29, 2020 , ... Medrio, Inc., the leading ... markets, has enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics ... their first patient in (FPI) in just seven days. The Cytovale technology will ...
Breaking Biology Technology:
Cached News: